Integrated Filing — IndAS



General information about company

Scrip Code 544122
NSE Symbol ENTERO
MSEI Symbol NOTLISTED
ISIN INE010601016
Name of company Entero Healthcare Solutions Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 03-02-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Distribution of Pharmaceuticals, surgicals and other healthcare and allied products
Start date and time of board meeting 12-02-2026   15:00:00
End date and time of board meeting 12-02-2026   17:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no Default on Loans or Debt Securities No. of times funds raised during the quarter- the Company has not raised funds during the quarter, however inorder to enable the tab of Statement of Deviation, we have selected 1 from the dropdown.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 10,673.60 26,930.90
Other income 2,325.40 7,376.70
Total income 12,999.00 34,307.60
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 7,132.70 22,853.60
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 2,666.80 1,032.50
(d) Employee benefit expense 1,513.30 4,343.90
(e) Finance costs 69.90 200.40
(f) Depreciation, depletion and amortisation expense 279.90 894.40
(f) Other Expenses
1 Legal and professional charges 169.40 639.20
2 Distribution cost 121.50 548.80
3 Travelling expenses 136.40 330.70
4 Business promotion expenses 121.20 361.40
5 Housekeeping expenses 66.40 107.30
6 IT expenses 48.20 155.20
7 Sign on amount 30.90 92.90
8 Power and fuel 22.10 85.50
9 Insurance 15.70 84.90
10 Miscellaneous expenses 17.50 312.40
Total other expenses 749.30 2,718.30
Total expenses 12,411.90 32,043.10
3 Total profit before exceptional items and tax 587.10 2,264.50
4 Exceptional items (449.70) (449.70)
5 Total profit before tax 137.40 1,814.80
6 Tax expense
7 Current tax 698.80 879.10
8 Deferred tax (641.90) (410.20)
9 Total tax expenses 56.90 468.90
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 80.50 1,345.90
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 80.50 1,345.90
17 Other comprehensive income net of taxes (1.10) (6.60)
18 Total Comprehensive Income for the period 79.40 1,339.30
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 4,351.10 4,351.10
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.18 3.09
Diluted earnings (loss) per share from continuing operations 0.18 3.09
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.18 3.09
Diluted earnings (loss) per share from continuing and discontinued operations 0.18 3.09
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain / (loss) on defined benefit plan (1.50) (8.80)
Total Amount of items that will not be reclassified to profit and loss (1.50) (8.80)
2 Income tax relating to items that will not be reclassified to profit or loss (0.40) (2.20)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (1.10) (6.60)





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 13-02-2024
Amount Raised 95,133.00
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NIL
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment/prepayment, in full or part, of certain borrowings availed of by our Company Not Applicable 14,250.00 0.00 14,250.00 0.00
2 Funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026 Not Applicable 48,000.00 0.00 48,000.00 0.00
3 Pursuing inorganic growth initiatives through acquisitions Not Applicable 23,700.00 0.00 23,700.00 0.00
4 General corporate purposes Not Applicable 9,530.00 0.00 9,530.00 0.00


Signatory Details

Name of signatory Balakrishnan Natesan Kaushik
Designation of person Chief Financial Officer
Place Mumbai
Date 12-02-2026